Value through Innovation02 July 2015

Boehringer Ingelheim Press Releases

See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.

Press Release Archive

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 next

SPIRIVA®* celebrates 10 years of ongoing commitment to patients and advancing clinical innovation in COPD

- For medical media outside the USA and UK

New data show significant improvements in lung function using combination of tiotropium and olodaterol* in COPD patients

- For Media outside the U.S. and UK

Phase III results: tiotropium* Respimat® significantly reduces exacerbations in asthma patients still symptomatic despite ICS/LABA treatment

- For Media outside the U.S. and UK

New bottle for Ingelvac MycoFLEX® simplifies mixing with Ingelvac CircoFLEX®


Large scale registry shows atrial fibrillation management is suboptimal and unequal around the world

- For Non-US, Non-UK & Non-Canadian Media Only

Key results from new tiotropium studies in COPD and asthma
to be presented at ERS 2012

- For Media outside the U.S. and UK

Clinical experience with Pradaxa® crosses one million patient-years of treatment

- For Non-US, Non-UK & Non-Canadian Media Only

Boehringer Ingelheim achieves further growth in first half of 2012 – difficult business environment expected for the second half of the year


Boehringer Ingelheim Biopharmaceuticals announces manufacturing agreement with Servier


Jentadueto® (linagliptin/metformin hydrochloride) tablets receive approval for the treatment of adults with Type 2 Diabetes in Europe

- For Non-U.S. and Non-UK Media

Boehringer Ingelheim and Funxional Therapeutics announce acquisition of Funxional’s FX125L and the somatotaxin portfolio to treat inflammation


Ilka Diester wins Boehringer Ingelheim’s FENS Award 2012 for Exceptional Research in Neuroscience

- For Non-US, Non-UK & Non-Canadian Media Only

Boehringer Ingelheim pursuing health care innovation – new collaboration with Healthrageous, Inc on a digital diabetes self-management program


Boehringer Ingelheim Establishes Translational Research Collaboration with Harvard University in Areas of Unmet Medical Need


Boehringer Ingelheim announces changes to Board of Managing Directors: Joachim Hasenmaier to lead new Board Division Consumer Healthcare and Animal Health


New publication in The Lancet: Two-year study in over 1,500 patients compares Trajenta® (linagliptin) to the commonly prescribed sulphonylurea glimepiride

- EX US & UK Medical Media Only

No significant difference in the risk of Acute Coronary Syndrome (including Myocardial Infarction) seen with Pradaxa® (dabigatran etexilate) compared to enoxaparin for VTE prevention after orthopaedic surgery


First study to evaluate alternative to warfarin for mechanical heart valve patients launched with Pradaxa® (dabigatran etexilate)

- For Non-US, Non-UK & Non-Canadian Media Only
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 next